KAPLAN PHARMACOLOGY QUESTIONS
AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES 2026 Q&A |
INSTANT DOWNLOAD PDF
Core Domains:
• General Pharmacological Principles (Pharmacokinetics and
Pharmacodynamics)
• Autonomic Nervous System Pharmacology
• Cardiovascular Pharmacology
• Central Nervous System Pharmacology
• Endocrine Pharmacology
• Anti-infective and Antimicrobial Therapy
• Gastrointestinal and Respiratory Pharmacology
• Oncology, Toxicology, and Antidotes
Introduction
This comprehensive examination is designed to assess a candidate's
mastery of core pharmacological principles and their application in
clinical practice. The exam covers a broad spectrum of topics, from
foundational concepts of drug absorption, distribution, metabolism, and
excretion to the therapeutic use and adverse effects of major drug classes.
The structure integrates multiple-choice questions and clinical scenario-
based items to evaluate critical thinking and clinical decision-making
skills. Emphasis is placed on the safe and effective application of
pharmacologic knowledge, including identifying drug interactions,
understanding regulatory guidelines, and making ethically sound, patient-
centered decisions. Candidates are expected to demonstrate proficiency
in applying pharmacologic principles to real-world patient care scenarios.
,SECTION ONE: QUESTIONS 1-100
Question 1
A nurse is preparing to administer an oral medication that undergoes
extensive first-pass metabolism. Which route of administration would
provide the highest bioavailability for this drug?
A. Oral
B. Rectal
C. Sublingual
D. Intravenous
D. Intravenous
RATIONALE: Intravenous (IV) administration delivers the drug
directly into the systemic circulation, completely bypassing the
gastrointestinal tract and hepatic first-pass metabolism, resulting in
100% bioavailability . Oral drugs (A) undergo significant metabolism in
the liver. Rectal (B) and sublingual (C) routes partially bypass the liver
but are not as complete as IV.
Question 2
A patient is prescribed a medication with a half-life of 4 hours.
Approximately how long will it take for the drug to reach a steady-state
plasma concentration?
A. 8 hours
B. 20 hours
C. 40 hours
D. 80 hours
B. 20 hours
RATIONALE: Steady-state concentration is typically achieved after
approximately 4 to 5 half-lives of drug administration . For a drug with a
half-life of 4 hours, it would take roughly 4 x 5 = 20 hours.
,Question 3
A patient is prescribed a drug with a narrow therapeutic index. Which of
the following is the most appropriate nursing action?
A. Monitor serum drug levels frequently.
B. Administer the drug on an empty stomach.
C. Increase the dose to ensure therapeutic efficacy.
D. Decrease the frequency of monitoring.
A. Monitor serum drug levels frequently.
RATIONALE: A narrow therapeutic index means there is a small
margin between the therapeutic and toxic doses of a drug . Frequent
monitoring of serum drug levels is essential to maintain the drug
concentration within a safe and effective range and prevent toxicity .
Question 4
A patient is prescribed a medication that is a CYP450 enzyme inducer.
The nurse should monitor for which effect on concurrently administered
drugs that are CYP450 substrates?
A. Increased serum levels and toxicity.
B. Decreased therapeutic effect.
C. No change in serum levels.
D. Decreased risk of adverse effects.
B. Decreased therapeutic effect.
RATIONALE: CYP450 enzyme inducers increase the metabolic
activity of the liver, leading to faster breakdown of other medications
that are substrates of the same enzyme. This results in lower serum
concentrations and a decreased therapeutic effect of the affected drugs .
Question 5
A client is prescribed a medication that is highly protein-bound. Which
physiological change would most likely increase the risk of toxicity?
A. Increased serum albumin levels.
B. Decreased serum albumin levels.
, C. Increased glomerular filtration rate.
D. Decreased hepatic blood flow.
B. Decreased serum albumin levels.
RATIONALE: A decrease in serum albumin reduces the protein-
binding capacity, leading to an increased free (unbound) fraction of
highly protein-bound drugs . This increased free fraction can lead to
greater drug distribution and potential toxicity .
Question 6
Which of the following medications should not be crushed?
A. Metoprolol tablet
B. Oxycodone capsule
C. Nifedipine extended-release
D. Acetaminophen tablet
C. Nifedipine extended-release
RATIONALE: Extended-release (ER/XR) formulations are designed to
release medication slowly over time. Crushing an extended-release
tablet destroys this mechanism, leading to dose dumping, rapid
absorption, and potential toxicity .
Question 7
An elderly patient is at higher risk for drug toxicity due to which
physiological change?
A. Decreased renal function
B. Decreased hepatic function
C. Increased body fat
D. All of the above
D. All of the above
RATIONALE: Elderly patients have decreased renal function
(reduced GFR), decreased hepatic function (reduced metabolism), and
increased body fat (increased volume of distribution for lipophilic
drugs) . These changes collectively increase the risk of drug toxicity.
AND CORRECT ANSWERS (VERIFIED
ANSWERS) PLUS RATIONALES 2026 Q&A |
INSTANT DOWNLOAD PDF
Core Domains:
• General Pharmacological Principles (Pharmacokinetics and
Pharmacodynamics)
• Autonomic Nervous System Pharmacology
• Cardiovascular Pharmacology
• Central Nervous System Pharmacology
• Endocrine Pharmacology
• Anti-infective and Antimicrobial Therapy
• Gastrointestinal and Respiratory Pharmacology
• Oncology, Toxicology, and Antidotes
Introduction
This comprehensive examination is designed to assess a candidate's
mastery of core pharmacological principles and their application in
clinical practice. The exam covers a broad spectrum of topics, from
foundational concepts of drug absorption, distribution, metabolism, and
excretion to the therapeutic use and adverse effects of major drug classes.
The structure integrates multiple-choice questions and clinical scenario-
based items to evaluate critical thinking and clinical decision-making
skills. Emphasis is placed on the safe and effective application of
pharmacologic knowledge, including identifying drug interactions,
understanding regulatory guidelines, and making ethically sound, patient-
centered decisions. Candidates are expected to demonstrate proficiency
in applying pharmacologic principles to real-world patient care scenarios.
,SECTION ONE: QUESTIONS 1-100
Question 1
A nurse is preparing to administer an oral medication that undergoes
extensive first-pass metabolism. Which route of administration would
provide the highest bioavailability for this drug?
A. Oral
B. Rectal
C. Sublingual
D. Intravenous
D. Intravenous
RATIONALE: Intravenous (IV) administration delivers the drug
directly into the systemic circulation, completely bypassing the
gastrointestinal tract and hepatic first-pass metabolism, resulting in
100% bioavailability . Oral drugs (A) undergo significant metabolism in
the liver. Rectal (B) and sublingual (C) routes partially bypass the liver
but are not as complete as IV.
Question 2
A patient is prescribed a medication with a half-life of 4 hours.
Approximately how long will it take for the drug to reach a steady-state
plasma concentration?
A. 8 hours
B. 20 hours
C. 40 hours
D. 80 hours
B. 20 hours
RATIONALE: Steady-state concentration is typically achieved after
approximately 4 to 5 half-lives of drug administration . For a drug with a
half-life of 4 hours, it would take roughly 4 x 5 = 20 hours.
,Question 3
A patient is prescribed a drug with a narrow therapeutic index. Which of
the following is the most appropriate nursing action?
A. Monitor serum drug levels frequently.
B. Administer the drug on an empty stomach.
C. Increase the dose to ensure therapeutic efficacy.
D. Decrease the frequency of monitoring.
A. Monitor serum drug levels frequently.
RATIONALE: A narrow therapeutic index means there is a small
margin between the therapeutic and toxic doses of a drug . Frequent
monitoring of serum drug levels is essential to maintain the drug
concentration within a safe and effective range and prevent toxicity .
Question 4
A patient is prescribed a medication that is a CYP450 enzyme inducer.
The nurse should monitor for which effect on concurrently administered
drugs that are CYP450 substrates?
A. Increased serum levels and toxicity.
B. Decreased therapeutic effect.
C. No change in serum levels.
D. Decreased risk of adverse effects.
B. Decreased therapeutic effect.
RATIONALE: CYP450 enzyme inducers increase the metabolic
activity of the liver, leading to faster breakdown of other medications
that are substrates of the same enzyme. This results in lower serum
concentrations and a decreased therapeutic effect of the affected drugs .
Question 5
A client is prescribed a medication that is highly protein-bound. Which
physiological change would most likely increase the risk of toxicity?
A. Increased serum albumin levels.
B. Decreased serum albumin levels.
, C. Increased glomerular filtration rate.
D. Decreased hepatic blood flow.
B. Decreased serum albumin levels.
RATIONALE: A decrease in serum albumin reduces the protein-
binding capacity, leading to an increased free (unbound) fraction of
highly protein-bound drugs . This increased free fraction can lead to
greater drug distribution and potential toxicity .
Question 6
Which of the following medications should not be crushed?
A. Metoprolol tablet
B. Oxycodone capsule
C. Nifedipine extended-release
D. Acetaminophen tablet
C. Nifedipine extended-release
RATIONALE: Extended-release (ER/XR) formulations are designed to
release medication slowly over time. Crushing an extended-release
tablet destroys this mechanism, leading to dose dumping, rapid
absorption, and potential toxicity .
Question 7
An elderly patient is at higher risk for drug toxicity due to which
physiological change?
A. Decreased renal function
B. Decreased hepatic function
C. Increased body fat
D. All of the above
D. All of the above
RATIONALE: Elderly patients have decreased renal function
(reduced GFR), decreased hepatic function (reduced metabolism), and
increased body fat (increased volume of distribution for lipophilic
drugs) . These changes collectively increase the risk of drug toxicity.
